Gene: COX6B2
Official Full Name: cytochrome c oxidase subunit 6B2provided by HGNC
Gene Summary: Predicted to be involved in oxidative phosphorylation. Located in mitochondrial crista. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO27478 | COX6B2 Knockout cell line (HeLa) | Human | COX6B2 | 1:3~1:6 | Negative | Online Inquiry |
KO27479 | COX6B2 Knockout cell line (HCT 116) | Human | COX6B2 | 1:2~1:4 | Negative | Online Inquiry |
KO27480 | COX6B2 Knockout cell line (HEK293) | Human | COX6B2 | 1:3~1:6 | Negative | Online Inquiry |
COX6B2 Gene Knockout Cell Lines are engineered cellular models that have undergone targeted gene disruption to eliminate the expression of the COX6B2 gene, which encodes a crucial subunit of cytochrome c oxidase, an essential component of the mitochondrial electron transport chain. By removing this gene, researchers can investigate the implications of its loss on cellular metabolism, oxidative phosphorylation, and overall mitochondrial function.
The key function of these knockout cell lines lies in their ability to serve as experimental tools for dissecting mitochondrial pathology associated with neurodegenerative diseases, cancer, and metabolic disorders. The mechanisms involved include the disruption of ATP synthesis and the consequent effects on cellular energy homeostasis. The absence of COX6B2 leads to a decrease in respiratory efficiency and increased reactive oxygen species (ROS) production, enabling researchers to model conditions that mimic mitochondrial dysfunction in vivo.
Scientifically, the applications of COX6B2 Gene Knockout Cell Lines extend to areas such as drug discovery, where understanding mitochondrial targets is critical in developing therapies for diseases linked to mitochondrial abnormalities. In clinical settings, these models provide insights into the role of mitochondrial impairment in diseases, guiding clinicians in devising targeted treatments.
One of the unique advantages of utilizing our COX6B2 Gene Knockout Cell Lines lies in our proprietary gene editing technology, which ensures high specificity and efficiency. This results in reproducible and robust knockout phenotypes, minimizing background noise associated with other gene alteration techniques. Compared to traditional cell lines or non-specific methods, our cell lines reduce experimental variability and enhance the reliability of data, making them indispensable tools in modern biological research.
For researchers and clinicians seeking to deepen their understanding of mitochondrial biology, our COX6B2 Gene Knockout Cell Lines represent a valuable resource that bridges the gap between basic research and clinical application. With a commitment to advancing functional genomics and cellular models, our company leverages years of expertise in genetic engineering to deliver high-quality products tailored for the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.